China Universal Asset Management Company’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

China Universal Asset Management Company’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-876	Closed	-$33.7K	–	461
2023 Q2	$33.7K	Sell	876 -16	-2%	-$411	0.01%	230
2023 Q1	$20.6K	Buy	892 +243	+37%	+$5.79K	0.01%	216
2022 Q4	$17K	Buy	649 +60	+10%	+$1.33K	0.01%	185
2022 Q3	$12K	Buy	+589	New	+$11.8K	0.01%	191

China Universal Asset Management Company's KDNY Position: Q3 2023 in Review

China Universal Asset Management Company sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 876 shares — an estimated $33.7K sold.

China Universal Asset Management Company first reported a position in KDNY in Q3 2022 and held it in 4 quarters. The position peaked at $33.7K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

China Universal Asset Management Company reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
China Universal Asset Management Company sold 876 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $33.7K.
China Universal Asset Management Company first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
China Universal Asset Management Company's Chinook Therapeutics, Inc. Common Stock position peaked at $33.7K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.